SGRY Quote, Financials, Valuation and Earnings

Encompass Health Corp. has a net margin of 3.08% compared to Surgery Partners, Inc.'s net margin of 13.1%. Surgery Partners, Inc.'s return on equity of 0.65% beat Encompass Health Corp.'s return on equity of 24.74%.

Surgery Partners, Inc. has a consensus price target of $25.45, signalling upside risk potential of 63.8%. On the other hand Encompass Health Corp. has an analysts' consensus of $142.73 which suggests that it could grow by 33.95%. Given that Surgery Partners, Inc. has higher upside potential than Encompass Health Corp., analysts believe Surgery Partners, Inc. is more attractive than Encompass Health Corp..

Surgery Partners, Inc. has a beta of 1.975, which suggesting that the stock is 97.487% more volatile than S&P 500. In comparison Encompass Health Corp. has a beta of 0.749, suggesting its less volatile than the S&P 500 by 25.06%.

Surgery Partners, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Encompass Health Corp. offers a yield of 0.68% to investors and pays a quarterly dividend of $0.19 per share. Surgery Partners, Inc. pays -- of its earnings as a dividend. Encompass Health Corp. pays out 13% of its earnings as a dividend. Encompass Health Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Surgery Partners, Inc. quarterly revenues are $821.5M, which are smaller than Encompass Health Corp. quarterly revenues of $1.5B. Surgery Partners, Inc.'s net income of $25.3M is lower than Encompass Health Corp.'s net income of $202.3M. Notably, Surgery Partners, Inc.'s price-to-earnings ratio is -- while Encompass Health Corp.'s PE ratio is 19.23x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Surgery Partners, Inc. is 0.60x versus 1.83x for Encompass Health Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Healthcare Services Group, Inc. has a net margin of 3.08% compared to Surgery Partners, Inc.'s net margin of 6.7%. Surgery Partners, Inc.'s return on equity of 0.65% beat Healthcare Services Group, Inc.'s return on equity of 11.82%.

Surgery Partners, Inc. has a consensus price target of $25.45, signalling upside risk potential of 63.8%. On the other hand Healthcare Services Group, Inc. has an analysts' consensus of $23.50 which suggests that it could grow by 13.86%. Given that Surgery Partners, Inc. has higher upside potential than Healthcare Services Group, Inc., analysts believe Surgery Partners, Inc. is more attractive than Healthcare Services Group, Inc..

Surgery Partners, Inc. has a beta of 1.975, which suggesting that the stock is 97.487% more volatile than S&P 500. In comparison Healthcare Services Group, Inc. has a beta of 0.746, suggesting its less volatile than the S&P 500 by 25.446%.

Surgery Partners, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Healthcare Services Group, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Surgery Partners, Inc. pays -- of its earnings as a dividend. Healthcare Services Group, Inc. pays out -- of its earnings as a dividend.

Surgery Partners, Inc. quarterly revenues are $821.5M, which are larger than Healthcare Services Group, Inc. quarterly revenues of $466.7M. Surgery Partners, Inc.'s net income of $25.3M is lower than Healthcare Services Group, Inc.'s net income of $31.2M. Notably, Surgery Partners, Inc.'s price-to-earnings ratio is -- while Healthcare Services Group, Inc.'s PE ratio is 25.31x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Surgery Partners, Inc. is 0.60x versus 0.82x for Healthcare Services Group, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Pediatrix Medical Group, Inc. has a net margin of 3.08% compared to Surgery Partners, Inc.'s net margin of 6.82%. Surgery Partners, Inc.'s return on equity of 0.65% beat Pediatrix Medical Group, Inc.'s return on equity of 19.95%.

Surgery Partners, Inc. has a consensus price target of $25.45, signalling upside risk potential of 63.8%. On the other hand Pediatrix Medical Group, Inc. has an analysts' consensus of $21.50 which suggests that it could grow by 14.24%. Given that Surgery Partners, Inc. has higher upside potential than Pediatrix Medical Group, Inc., analysts believe Surgery Partners, Inc. is more attractive than Pediatrix Medical Group, Inc..

Surgery Partners, Inc. has a beta of 1.975, which suggesting that the stock is 97.487% more volatile than S&P 500. In comparison Pediatrix Medical Group, Inc. has a beta of 0.759, suggesting its less volatile than the S&P 500 by 24.082%.

Surgery Partners, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Pediatrix Medical Group, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Surgery Partners, Inc. pays -- of its earnings as a dividend. Pediatrix Medical Group, Inc. pays out -- of its earnings as a dividend.

Surgery Partners, Inc. quarterly revenues are $821.5M, which are larger than Pediatrix Medical Group, Inc. quarterly revenues of $493.8M. Surgery Partners, Inc.'s net income of $25.3M is lower than Pediatrix Medical Group, Inc.'s net income of $33.7M. Notably, Surgery Partners, Inc.'s price-to-earnings ratio is -- while Pediatrix Medical Group, Inc.'s PE ratio is 9.71x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Surgery Partners, Inc. is 0.60x versus 0.84x for Pediatrix Medical Group, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

U.S. Physical Therapy, Inc. has a net margin of 3.08% compared to Surgery Partners, Inc.'s net margin of 9.98%. Surgery Partners, Inc.'s return on equity of 0.65% beat U.S. Physical Therapy, Inc.'s return on equity of 8.6%.

Surgery Partners, Inc. has a consensus price target of $25.45, signalling upside risk potential of 63.8%. On the other hand U.S. Physical Therapy, Inc. has an analysts' consensus of $105.33 which suggests that it could grow by 23.79%. Given that Surgery Partners, Inc. has higher upside potential than U.S. Physical Therapy, Inc., analysts believe Surgery Partners, Inc. is more attractive than U.S. Physical Therapy, Inc..

Surgery Partners, Inc. has a beta of 1.975, which suggesting that the stock is 97.487% more volatile than S&P 500. In comparison U.S. Physical Therapy, Inc. has a beta of 1.297, suggesting its more volatile than the S&P 500 by 29.702%.

Surgery Partners, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. U.S. Physical Therapy, Inc. offers a yield of 2.12% to investors and pays a quarterly dividend of $0.45 per share. Surgery Partners, Inc. pays -- of its earnings as a dividend. U.S. Physical Therapy, Inc. pays out 95.62% of its earnings as a dividend. U.S. Physical Therapy, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Surgery Partners, Inc. quarterly revenues are $821.5M, which are larger than U.S. Physical Therapy, Inc. quarterly revenues of $197.1M. Surgery Partners, Inc.'s net income of $25.3M is higher than U.S. Physical Therapy, Inc.'s net income of $19.7M. Notably, Surgery Partners, Inc.'s price-to-earnings ratio is -- while U.S. Physical Therapy, Inc.'s PE ratio is 35.80x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Surgery Partners, Inc. is 0.60x versus 1.70x for U.S. Physical Therapy, Inc.. Usually stocks with elevated PS ratios are considered overvalued.